Cite

HARVARD Citation

    Relias, V. et al. (2021). Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists. Journal of oncology pharmacy practice. pp. 658-672. [Online]. 
  
Back to record